Foghorn Therapeutics Inc.

FHTX·NASDAQ·$4.37Share Price as of 11/2·$257MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/11/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/05/25

Disclosures

8-KCurrent report10/01/26 8-KCurrent report08/06/26 8-KCurrent report06/24/26 8-KCurrent report05/07/26 8-KCurrent report04/21/26

Prospectuses and Registrations

S-8Registration of securities for employees03/26/26 424B5Prospectus supplement01/12/26 424B5Prospectus supplement03/20/25 S-3Shelf registration01/24/25 S-8Registration of securities for employees01/24/25

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 DEF 14ADefinitive proxy05/05/25 DEFA14AAdditional proxy materials05/05/25 DEF 14ADefinitive proxy05/03/24

Ownership

Form 3Initial insider ownership10/05/26 SC 13G/ABeneficial ownership (amended)10/05/26 Form 4Insider transaction06/25/26 Form 4Insider transaction06/25/26 Form 4Insider transaction06/25/26

Other

ARSAnnual report to shareholders04/30/26 ARSAnnual report to shareholders05/05/25 EFFECTRequest for effectiveness01/31/25 CORRESPCorrespondence with the SEC01/29/25 UPLOADLetter from the SEC01/29/25